Prudential Financial’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $19.4M | Buy |
|
|||||
|
2025
Q2 | $14.8M | Buy |
|
|||||
|
2025
Q1 | $5.89M | Buy |
|
|||||
|
2024
Q4 | $4.66M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $582K | Sell |
|
|||||
|
2024
Q1 | $19.8M | Buy |
|
|||||
|
2023
Q4 | $13.9M | Buy |
|
|||||
|
2023
Q3 | $6.83M | Buy |
|
|||||
|
2023
Q2 | $3.82M | Buy |
|
|||||
|
2023
Q1 | $757K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $283K | Sell |
|
|||||
|
2022
Q2 | $373K | Buy |
|
|||||
|
2022
Q1 | $575K | Buy |
|
|||||
|
2021
Q4 | $230K | Sell |
|
|||||
|
2021
Q3 | $174K | Buy |
|
|||||
|
2021
Q2 | $248K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $3M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $5.98M | Sell |
|
|||||
|
2020
Q1 | $12.7M | Sell |
|
|||||
|
2019
Q4 | $17.5M | Buy |
|
|||||
|
2019
Q3 | $14.2M | Buy |
|
|||||
|
2019
Q2 | $5.74M | Buy |
|
|||||
|
2019
Q1 | $1.26M | Buy |
|
|||||
|
2018
Q4 | $201K | Buy |
|
|||||
|
2018
Q3 | $239K | Sell |
|
|||||
|
2018
Q2 | $178K | Sell |
|
|||||
|
2018
Q1 | $2.78M | Sell |
|
|||||
|
2017
Q4 | $7.3M | Buy |
|
|||||
|
2017
Q3 | $6.57M | Sell |
|
|||||
|
2017
Q2 | $5.14M | Buy |
|
|||||
|
2017
Q1 | $5.88M | Sell |
|
|||||
|
2016
Q4 | $5.73M | Buy |
|
|||||
|
2016
Q3 | $269K | Buy |
|
|||||
|
2016
Q2 | $262K | Buy |
|
|||||
|
2016
Q1 | $213K | Buy |
|
|||||
|
2015
Q4 | $261K | Sell |
|
|||||
|
2015
Q3 | $256K | Buy |
|
|||||
|
2015
Q2 | $320K | Sell |
|
|||||
|
2015
Q1 | $253K | Hold |
|
|||||
|
2014
Q4 | $246K | Sell |
|
|||||
|
2014
Q3 | $209K | Sell |
|
|||||
|
2014
Q2 | $376K | Buy |
|
|||||
|
2014
Q1 | $206K | Buy |
|
|||||
|
2013
Q4 | $204K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $318K | Buy |
|